STEPHANIE TANWANGCO: Open Payments
NPI 1548985203 · GRANITE CITY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 38 payments from 10 companies in 2025. Trend: 2023 $71 · 2024 $407 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $243 |
| Vanda Pharmaceuticals Inc. | 8 | $198 |
| Neurocrine BioSciences, Inc. | 5 | $87 |
| Braeburn Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Indivior Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: FANAPT, ARISTADA, VIVITROL, INGREZZA, BRIXADI, CAPLYTA, SUBLOCADE, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
